Anúncio
Anúncio

PYXS

PYXS logo

Pyxis Oncology, Inc. Common Stock

1.44
USD
Patrocinado
+0.14
+10.38%
07 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

1.49

+0.05
+3.48%

Relatórios de Lucros PYXS

Rácio de surpresa positiva

PYXS separação 7 de 17 últimas estimativas.

41%

Próximo Relatório

Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.34
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
-2.86%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+36.00%

Pyxis Oncology, Inc. Common Stock earnings per share and revenue

On 03 de nov. de 2025, PYXS reported earnings of -0.35 USD per share (EPS) for Q3 25, missing the estimate of -0.34 USD, resulting in a -1.36% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.02% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analistas forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an diminuir of -2.86% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Pyxis Oncology, Inc. Common Stock reported EPS of -$0.35, missing estimates by -1.36%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.02%, changed from $3.56 before the earnings release to $3.81 the day after.
The next earning report is scheduled for 16 de mar. de 2026.
Based on 11 analistas, Pyxis Oncology, Inc. Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio